StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech gross margin

Gross margin is gross profit as a percentage of revenue.

XBiotech's gross margin for the twelve months ending Sep 30, 2023 was 94.7%. For fiscal 2022 it was 83.8%, against 68.4% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 202283.8%+15.4
FY2021Dec 31, 202168.4%+46.9
FY2020Dec 31, 202021.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2022Dec 31, 202294.7%+17.9
Q3 FY2022Sep 30, 202287.2%+11.8
Q2 FY2022Jun 30, 202286.5%+16.5
Q1 FY2022Mar 31, 202257.4%+4.9
Q4 FY2021Dec 31, 202176.8%+19.4
Q3 FY2021Sep 30, 202175.4%+64.8
Q2 FY2021Jun 30, 202169.9%+55.1
Q1 FY2021Mar 31, 202152.5%+28.8
Q4 FY2020Dec 31, 202057.3%–
Q3 FY2020Sep 30, 202010.6%–
Q2 FY2020Jun 30, 202014.8%–
Q1 FY2020Mar 31, 202023.7%–

More XBiotech figures

See a number that looks wrong?